Induced neural stem cells: Methods of reprogramming and potential therapeutic applications

Progress in Neurobiology

Volumn 114, Issue , 2014, Pages 15-24

  Ruggieri, Margherita ^a   Riboldi, Giulietta ^a   Brajkovic, Simona ^a   Bucchia, Monica ^a   Bresolin, Nereo ^a,b   Comi, Giacomo P ^a   Corti, Stefania ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SCIENTIFIC INSTITUTE   (Italy)

Author keywords

Clinical application; Induced neural stem cells; Multipotency; Reprogramming; Self renewal

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BETA TUBULIN; CONNECTIVE TISSUE GROWTH FACTOR; CRE RECOMBINASE; DOUBLECORTIN; FIBROBLAST GROWTH FACTOR 2; GLIAL FIBRILLARY ACIDIC PROTEIN; KRUPPEL LIKE FACTOR 4; MICRORNA 124; MICRORNA 9; MICROTUBULE ASSOCIATED PROTEIN 2; MYC PROTEIN; NESTIN; NEUROGENIN 2; NEURON SPECIFIC NUCLEAR PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PROTEOLIPID PROTEIN; STAGE SPECIFIC EMBRYO ANTIGEN 1; TRANSCRIPTION FACTOR 7 LIKE 1; TRANSCRIPTION FACTOR LHX3; TRANSCRIPTION FACTOR MASH1; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR SOX1; TRANSCRIPTION FACTOR SOX3; TYROSINE 3 MONOOXYGENASE;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ASTROCYTE; BIOTRANSFORMATION; CELL DIFFERENTIATION; CELL RENEWAL; CELL TRANSDIFFERENTIATION; COLONY FORMING CELL; DEMETHYLATION; FIBROBLAST; HUMAN; IMMUNOGENICITY; INDUCED NEURAL STEM CELL; MULTIPLE SCLEROSIS; MULTIPOTENT STEM CELL; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR REPROGRAMMING; OLIGODENDROGLIA; PARKINSON DISEASE; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SOMATIC CELL; SPINAL MUSCULAR ATROPHY; TRANSIENT EXPRESSION;

CLINICAL APPLICATION; INDUCED NEURAL STEM CELLS; MULTIPOTENCY; REPROGRAMMING; SELF-RENEWAL;

ANIMALS; BRAIN DISEASES; CELL DIFFERENTIATION; HUMANS; NEURAL STEM CELLS;

EID: 84896396125     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2013.11.001     Document Type: Review

References (99)

1. Alper J. Geron gets green light for human trial of ES cell derived product. Nat. Biotechnol. 2009, 27:213-214.
2. Anokye-Danso F., Trivedi C.M., Juhr D., Gupta M., Cui Z., Tian Y., Zhang Y., Yang W., Gruber P.J., Epstein J.A., Morrisey E.E. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell. 2011, 8:376-388.
3. Bichsel C., Neeld D., Hamazaki T., Chang L.J., Yang L.J., Terada N., Jin S. Direct reprogramming of fibroblasts to myocytes via bacterial injection of MyoD protein. Cell Reprogram 2013, 15(2):117-125.
4. Brambrink T., Foreman R., Welstead G.G., Lengner C.J., Wernig M., Suh H., Jaenisch R. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell. 2008, 27(2):151-159.
5. Brennand K.J., Simone A., Jou J., Gelboin-Burkhart C., Tran N., Sangar S., Li Y., Mu Y., Chen G., Yu D., McCarthy S., Sebat J., Gage F.H. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011, 473(7346):221-225.
6. Brett J.O., Renault V.M., Rafalski V.A., Webb A.E., Brunet A. The microRNA cluster miR-106b~25 regulates adult neural stem/progenitor cell proliferation and neuronal differentiation. Aging (Albany, NY) 2011, 3(2):108-124.
7. Buganim Y., Itskovich E., Hu Y.C., Cheng A.W., Ganz K., Sarkar S., Fu D., Welstead G.G., Page D.C., Jaenisch R. Direct reprogramming of fibroblasts into embryonic Sertoli-like cells by defined factors. Cell Stem Cell 2012, 11(3):373-386.
8. Bylund M., Andersson E., Novitch B.G., Muhr J. Vertebrate neurogenesis is counteracted by Sox1-3 activity. Nat. Neurosci. 2003, 6(11):1162-1168.
9. Caiazzo M., Dell'Anno M.T., Dvoretskova E., Lazarevic D., Taverna S., Leo D., Sotnikova T.D., Menegon A., Roncaglia P., Colciago G., Russo G., Carninci P., Pezzoli G., Gainetdinov R.R., Gustincich S., Dityatev A., Broccoli V. Direct generation of functional dopaminergic neurons from mouse and human fibroblasts. Nature 2011, 476(7359):224-227.
10. Chang C.W., Lai Y.S., Pawlik K.M., Liu K., Sun C.W., Li C., Schoeb T.R., Townes T.M. Polycistronic lentiviral vector for hit and run reprogramming of adult skin fibroblasts to induced pluripotent stem cells. Stem Cells 2009, 27(5):1042-1049.
11. Cheng L.C., Pastrana E., Tavazoie M., Doetsch F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat. Neurosci. 2009, 12:399-408.
12. Coolen M., Thieffry D., Drivenes Ø., Becker T.S., Bally-Cuif L. miR-9 controls the timing of neurogenesis through the direct inhibition of antagonistic factors. Dev. Cell. 2012, 22(5):1052-1064.
13. Corti S., Nizzardo M., Nardini M., Donadoni C., Salani S., Ronchi D., Saladino F., Bordoni A., Fortunato F., Del Bo R., Papadimitriou D., Locatelli F., Menozzi G., Strazzer S., Bresolin N., Comi G.P. Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy. J. Clin. Invest. 2008, 118(10):3316-3330.
14. Delaloy C., Gao F.B. A new role for microRNA-9 in human neural progenitor cells. Cell Cycle 2010, 9(15):2913-2914.
15. Dimos J.T., Rodolfa K.T., Niakan K.K., Weisenthal L.M., Mitsumoto H., Chung W., Croft G.F., Saphier G., Leibel R., Goland R., Wichterle H., Henderson C.E., Eggan K. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008, 321(5893):1218-1221.
16. Doetsch F. The glial identity of neural stem cells. Nat. Neurosci. 2003, 6:1127-1134.
17. Doetsch F., Caillé I., Lim D.A., García-Verdugo J.M., Alvarez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 1999, 97(6):703-716.
18. Dolgin E. Flaw in induced-stem-cell model. Nature 2011, 470:13.
19. Ebert.A.D., Yu J., Rose F.F., Mattis V.B., Lorson C.L., Thomson J.A., Svendsen C.N. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 2009, 457(7227):277-280.
20. Efe J.A., Hilcove S., Kim J., Zhou H., Ouyang K., Wang G., Chen J., Ding S. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat. Cell. Biol. 2011, 13(3):215-222.
21. Ellis P., Fagan B.M., Magness S.T., Hutton S., Taranova O., Hayashi S., McMahon A., Rao M., Pevny L. SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult. Dev. Neurosci. 2004, 26(2-4):148-165.
22. Fong C.Y., Gauthaman K., Bongso A. Teratomas from pluripotent stem cells: a clinical hurdle. J. Cell. Biochem. 2010, 111(4):769-781. (Review).
23. Fusaki N., Ban H., Nishiyama A., Saeki K., Hasegawa M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc. Jpn. Acad. Ser. B: Phys. Biol. Sci. 2009, 85(8):348-362.
24. Gómez-López S., Wiskow O., Favaro R., Nicolis S.K., Price D.J., Pollard S.M., Smith A. Sox2 and Pax6 maintain the proliferative and developmental potential of gliogenic neural stem cells in vitro. Glia 2011, 59(11):1588-1599.
25. Graham V., Khudyakov J., Ellis P., Pevny L. SOX2 functions to maintain neural progenitor identity. Neuron 2003, 39(5):749-765.
26. Han D.W., Greber B., Wu G., Tapia N., Araúzo-Bravo M.J., Ko K., Bernemann C., Stehling M., Schöler H.R. Direct reprogramming of fibroblasts into epiblast stem cells. Nat. Cell Biol. 2011, 13(1):66-71.
27. Han D.W., Tapia N., Hermann A., Hemmer K., Höing S., Araúzo-Bravo M.J., Zaehres H., Wu G., Frank S., Moritz S., Greber B., Yang J.H., Lee H.T., Schwamborn J.C., Storch A., Schöler H.R. Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell. 2012, 10(4):465-472.
28. Hanna J., Saha K., Pando B., van Zon J., Lengner C.J., Creyghton M.P., Van Oudenaarden A., Jaenisch R. Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 2009, 462(7273):595-601.
29. Hatakeyama J., Kageyama R. Notch1 expression is spatiotemporally correlated with neurogenesis and negatively regulated by Notch1-independent Hes genes in the developing nervous system. Cereb. Cortex 2006, 16(Suppl. 1):i132L 7.
30. Huang P., He Z., Ji S., Sun H., Xiang D., Liu C., Hu Y., Wang X., Hui L. Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature 2011, 475(7356):386-389.
31. Karussis D., Petrou P., Kassis I. Clinical experience with stem cells and other cell therapies in neurological diseases?. J. Neurol. Sci. 2013, 324(1-2):1-9.
32. Ieda M., Fu J.D., Delgado-Olguin P., Vedantham V., Hayashi Y., Bruneau B.G., Srivastava D. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 2010, 142(3):375-386.
33. Ilieva H., Polymenidou M., Cleveland D.W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell. Biol. 2009, 187:761-772.
34. Ince-Dunn G., Hall B.J., Hu S.C., Ripley B., Huganir R.L., Olson J.M., Tapscott S.J., Ghosh A. Regulation of thalamocortical patterning and synaptic maturation by NeuroD2. Neuron 2006, 49(5):683-695.
35. Israel M.A., Yuan S.H., Bardy C., Reyna S.M., Mu Y., Herrera C., Hefferan M.P., Van Gorp S., Nazor K.L., Boscolo F.S., Carson C.T., Laurent L.C., Marsala M., Gage F.H., Remes A.M., Koo E.H., Goldstein L.S. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells. Nature 2012, 482(7384):216-220.
36. Kageyama R., Ohtsuka T., Kobayashi T. Roles of Hes genes in neural development. Dev. Growth Differ. 2008, 50(Suppl. 1):S97L 103.
37. Kaji K., Norrby K., Paca A., Mileikovsky M., Mohseni P., Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009, 9458(7239):771-775.
38. Karussis D., Karageorgiou C., Vaknin-Dembinsky A., Gowda-Kurkalli B., Gomori J.M., Kassis I., Bulte J.W., Petrou P., Ben-Hur T., Abramsky O., Slavin S. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch. Neurol. 2010, 67:1187-1194.
39. Keirstead H.S., Nistor G., Bernal G., Totoiu M., Cloutier F., Sharp K., Steward O. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J. Neurosci. 2005, 25:4694-4705.
40. Kim D., Kim C.H., Moon J.I., Chung Y.G., Chang M.Y., Han B.S., Ko S., Yang E., Cha K.Y., Lanza R., Kim K.S. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell. 2009, 4(6):472-476.
41. Kim J., Efe J.A., Zhu S., Talantova M., Yuan X., Wang S., Lipton S.A., Zhang K., Ding S. Direct reprogramming of mouse fibroblasts to neural progenitors. Proc. Natl. Acad. Sci. U.S.A. 2011, 108(19):7838-7843.
42. Larijani B., Esfahani E.N., Amini P., Nikbin B., Alimoghaddam K., Amiri S., Malekzadeh R., Yazdi N.M., Ghodsi M., Dowlati Y., Sahraian M.A., Ghavamzadeh A. Stem cell therapy in treatment of different diseases. Acta Med Iran. 2012, 50(2):79-96.
43. Lee H.J., Lee J.K., Lee H., Shin J.W., Carter J.E., Sakamoto T., Jin H.K., Bae J.S. The therapeutic potential of human umbilical cord blood-derived mesenchymal stem cells in Alzheimer's disease. Neurosci. Lett. 2010, 481(1):30-35.
44. Lendahl U., Zimmerman L.B., McKay R.D. CNS stem cells express a new class of intermediate filament protein. Cell 1990, 60(4):585-595.
45. Li X.K., Jin P. Roles of small regulatory RNAs in determining neuronal identity. Nat. Rev. Neurosci. 2010, 11:329-338.
46. Lin C.H., Hansen S., Wang Z., Storm D.R., Tapscott S.J., Olson J.M. The dosage of the neuroD2 transcription factor regulates amygdala development and emotional learning. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(41):14877-14882.
47. Liu C.M., Teng Z.Q., Santistevan N.J., Szulwach K.E., Guo W.X., Jin P., Zhao X.Y. Epigenetic regulation of miR-184 by MBD1 governs neural stem cell proliferation and differentiation. Cell Stem Cell 2010, 6:433-444.
48. Liu X., Li F., Stubblefield E.A., Blanchard B., Richards T.L., Larson G.A., He Y., Huang Q., Tan A.C., Zhang D., Benke T.A., Sladek J.R., Zahniser N.R., Li C.Y. Direct reprogramming of human fibroblasts into dopaminergic neuron-like cells. Cell Res. 2012, 22(2):321-332.
49. Lujan E., Chanda S., Ahlenius H., Südhof T.C., Wernig M. Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells. Proc. Natl. Acad. Sci. U.S.A. 2012, 109(7):2527-2532.
50. Lunn J.S., Sakowski S.A., Federici T., Glass J.D., Boulis N.M., Feldman E.L. Stem cell technology for the study and treatment of motor neuron diseases. Regen. Med. 2011, 6:201-213.
51. Maherali N., Sridharan R., Xie W., Utikal J., Eminli S., Arnold K., Stadtfeld M., Yachechko R., Tchieu J., Jaenisch R., Plath K., Hochedlinger K. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 2007, 1(1):55-70.
52. Marro S., Pang Z.P., Yang N., Tsai M.C., Qu K., Chang H.Y., Südhof T.C., Wernig M. Direct lineage conversion of terminally differentiated hepatocytes to functional neurons. Cell Stem Cell 2011, 9(4):374-382.
53. Matsui T., Takano M., Yoshida K., Ono S., Fujisaki C., Matsuzaki Y., Toyama Y., Nakamura M., Okano H., Akamatsu W. Neural stem cells directly differentiated from partially reprogrammed fibroblasts rapidly acquire gliogenic competency. Stem Cells 2012, 30(6):1109-1119.
54. Miura K., Okada Y., Aoi T., Okada A., Takahashi K., Okita K., Nakagawa M., Koyanagi M., Tanabe K., Ohnuki M., Ogawa D., Ikeda E., Okano H., Yamanaka S. Variation in the safety of induced pluripotent stem cell lines. Nat. Biotechnol. 2009, 27:743-745.
55. Moghadam F.H., Alaie H., Karbalaie K., Tanhaei S., Nasr Esfahani M.H., Baharvand H. Transplantation of primed or unprimed mouse embryonic stem cell-derived neural precursor cells improves cognitive function in Alzheimerian rats. Differentiation 2009, 78(2-3):59-68.
56. Nandoe Tewarie R.S., Hurtado A., Bartels R.H., Grotenhuis A., Oudega M. Stem cell-based therapies for spinal cord injury. J. Spinal. Cord Med. 2009, 32(2):105-114.
57. Nishino J., Kim I., Chada K., Morrison S.J. Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16(Ink4a) and p19(Arf) expression. Cell 2008, 135:227-239.
58. Okita K., Ichisaka T., Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448(7151):313-317.
59. Okita K., Matsumura Y., Sato Y., Okada A., Morizane A., Okamoto S., Hong H., Nakagawa M., Tanabe K., Tezuka K., Shibata T., Kunisada T., Takahashi M., Takahashi J., Saji H., Yamanaka S. A more efficient method to generate integration-free human iPS cells. Nat. Methods 2011, 8(5):409-412.
60. Okita K., Nakagawa M., Hyenjong H., Ichisaka T., Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008, 322(5903):949-953.
61. Park I.H., Arora N., Huo H., Maherali N., Ahfeldt T., Shimamura A., Lensch M.W., Cowan C., Hochedlinger K., Daley G.Q. Disease-specific induced pluripotent stem cells. Cell 2008, 134(5):877-886.
62. Pfisterer U., Kirkeby A., Torper O., Wood J., Nelander J., Dufour A., Björklund A., Lindvall O., Jakobsson J., Parmar M. Direct conversion of human fibroblasts to dopaminergic neurons. Proc. Natl. Acad. Sci. U.S.A. 2011, 108(25):10343-10348.
63. Politis M., Lindvall O. Clinical application of stem cell therapy in Parkinson's disease. BMC Med. 2012, 10(1).
64. Potten C.S., Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 1990, 110(4):1001-1020. (Review).
65. Rakic P. Neurogenesis in adult primate neocortex: an evaluation of the evidence. Nat. Rev. Neurosci. 2002, 3(1):65-71. (Review).
66. Reynolds B.A., Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992, 255(5052):1707-1710.
67. Ring K.L., Tong L.M., Balestra M.E., Javier R., Andrews-Zwilling Y., Li G., Walker D., Zhang W.R., Kreitzer A.C., Huang Y. Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor. Cell Stem Cell 2012, 11(1):100-109.
68. Sekiya S., Suzuki A. Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature 2011, 475(7356):390-393.
69. Seri B., Herrera D.G., Gritti A., Ferron S., Collado L., Vescovi A., Garcia-Verdugo J.M., Alvarez-Buylla A. Composition and organization of the SCZ: a large germinal layer containing neural stem cells in the adult mammalian brain. Cereb. Cortex 2006, 16(Suppl. 1):i103-i111.
70. Sheng C., Zheng Q., Wu J., Xu Z., Wang L., Li W., Zhang H., Zhao X.Y., Liu L., Wang Z., Guo C., Wu H.J., Liu Z., Wang L., He S., Wang X.J., Chen Z., Zhou Q. Direct reprogramming of Sertoli cells into multipotent neural stem cells by defined factors. Cell. Res. 2012, 22(1):208-218.
71. Soldner F., Laganière J., Cheng A.W., Hockemeyer D., Gao Q., Alagappan R., Khurana V., Golbe L.I., Myers R.H., Lindquist S., Zhang L., Guschin D., Fong L.K., Vu B.J., Meng X., Urnov F.D., Rebar E.J., Gregory P.D., Zhang H.S., Jaenisch R. Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. Cell 2011, 146(2):318-331.
72. Son E.Y., Ichida J.K., Wainger B.J., Toma J.S., Rafuse V.F., Woolf C.J., Eggan K. Conversion of mouse and human fibroblasts into functional spinal motor neurons. Cell Stem Cell 2011, 9(3):205-218.
73. Stadtfeld M., Maherali N., Breault D.T., Hochedlinger K. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2008, 2(3):230-240.
74. Stadtfeld M., Nagaya M., Utikal J., Weir G., Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science 2008, 322(5903):945-949.
75. Szabo E., Rampalli S., Risueño R.M., Schnerch A., Mitchell R., Fiebig-Comyn A., Levadoux-Martin M., Bhatia M. Direct conversion of human fibroblasts to multilineage blood progenitors. Nature 2010, 468(7323):521-526.
76. Szulwach K.E., Li X., Smrt R.D., Li Y., Luo Y., Lin L., Santistevan N.J., Li W., Zhao X., Jin P. Cross talk between microRNA and epigenetic regulation in adult neurogenesis. J Cell Biol 2010, 189:127-141.
77. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131(5):861-872.
78. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126(4):663-676.
79. Thier M., Wörsdörfer P., Lakes Y.B., Gorris R., Herms S., Opitz T., Seiferling D., Quandel T., Hoffmann P., Nöthen M.M., Brüstle O., Edenhofer F. Direct conversion of fibroblasts into stably expandable neural stem cells. Cell Stem Cell 2012, 10(4):473-479.
80. Thier M., Münst B., Edenhofer F. Exploring refined conditions for reprogramming cells by recombinant Oct4 protein. Int. J. Dev. Biol. 2010, 54(11-12):1713-1721.
81. Tsuji O., Miura K., Okada Y., Fujiyoshi K., Mukaino M., Nagoshi N., Kitamura K., Kumagai G., Nishino M., Tomisato S., Higashi H., Nagai T., Katoh H., Kohda K., Matsuzaki Y., Yuzaki M., Ikeda E., Toyama Y., Nakamura M., Yamanaka S., Okano H. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:12704-12709.
82. Vierbuchen T., Ostermeier A., Pang Z.P., Kokubu Y., Südhof T.C., Wernig M. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463(7284):1035-1041.
83. Wang H., Fang H., Dai J., Liu G., Xu Z.J. Induced pluripotent stem cells for spinal cord injury therapy: current status and perspective. Neurol. Sci. 2012, (published online: 15.07.12).
84. Warren L., Manos P.D., Ahfeldt T., Loh Y.H., Li H., Lau F., Ebina W., Mandal P.K., Smith Z.D., Meissner A., Daley G.Q., Brack A.S., Collins J.J., Cowan C., Schlaeger T.M., Rossi D.J. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 2010, 7(5):618-630.
85. Wernig M., Meissner A., Foreman R., Brambrink T., Ku M., Hochedlinger K., Bernstein B.E., Jaenisch R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 2007, 448(7151):318-324.
86. Wernig M., Zhao J.P., Pruszak J., Hedlund E., Fu D., Soldner F., Broccoli V., Constantine-Paton M., Isacson O., Jaenisch R. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:5856-5861.
87. Woltjen K., Michael I.P., Mohseni P., Desai R., Mileikovsky M., Hämäläinen R., Cowling R., Wang W., Liu P., Gertsenstein M., Kaji K., Sung H.K., Nagy A. PiggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009, 458:766-770.
88. Xuan A.G., Luo M., Ji W.D., Long D.H. Effects of engrafted neural stem cells in Alzheimer's disease rats. Neurosci. Lett. 2009, 450(2):167-171.
89. Yamanaka S. A fresh look at iPS cells. Cell 2009, 137:13-17.
90. Yoo A.S., Sun A.X., Li L., Shcheglovitov A., Portmann T., Li Y., Lee-Messer C., Dolmetsch R.E., Tsien R.W., Crabtree G.R. MicroRNA-mediated conversion of human fibroblasts to neurons. Nature 2011, 476(7359):228-231.
91. Yu J., Hu K., Smuga-Otto K., Tian S., Stewart R., Slukvin I.I., Thomson J.A. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009, 324(5928):797-801.
92. Zhang K., Liu G.H., Yi F., Montserrat N., Hishida T., Rodriguez Esteban C., Izpisua Belmonte J.C. Direct conversion of human fibroblasts into retinal pigment epithelium-like cells by defined factors. Protein Cell 2013, [Epub ahead of print].
93. Zhao C., Sun G.Q., Li S.X., Lang M.F., Yang S., Li W.D., Shi Y.H. MicroRNA let-7b regulates neural stem cell proliferation and differentiation by targeting nuclear receptor TLX signaling. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:1876-1881.
94. Zhao C., Sun G.Q., Li S.X., Shi Y.H. A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination. Nat. Struct. Mol. Biol. 2009, 16:365-371.
95. Zhao T., Zhang Z.N., Rong Z., Xu Y. Immunogenicity of induced pluripotent stem cells. Nature 2011, 474:212-215.
96. Zhou H., Wu S., Joo J.Y., Zhu S., Han D.W., Lin T., Trauger S., Bien G., Yao S., Zhu Y., Siuzdak G., Schöler H.R., Duan L., Ding S. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009, 4(5):381-384.
97. Zhou Q., Brown J., Kanarek A., Rajagopal J., Melton D.A. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008, 455(7213):627-632.
98. Zhu J., Pang D., Zhou Y., Tang X., Huang Y., Xie W., Gao F., Lai L., Zhang M., Ouyang H. Direct conversion of porcine embryonic fibroblasts into adipocytes by chemical molecules. Cell Reprogram 2012, 14(2):99-105.
99. Zhu W., Fan Y., Frenzel T., Gasmi M., Bartus R.T., Young W.L., Yang G.Y., Chen Y. Insulin growth factor-1 gene transfer enhances neurovascular remodeling and improves long-term stroke outcome in mice. Stroke 2008, 39(4):1254-1261.